How much does Choletec cost?

Pricing for Choletec varies by insurance plan, dose, and pharmacy. Our database does not show a fixed cost because prices change faster than we can verify. For current pharmacy prices, check your insurance's formulary tier (in the prior-authorization section), use the GoodRx or Cost Plus Drugs deep links on this page, or ask your pharmacist to run a test claim. If a copay card is listed, it usually drops the out-of-pocket significantly for commercial insurance.

Does Choletec need prior authorization?

Choletec appears on 1 payer formulary in our database. PA requirements vary by payer — see the prior-authorization table on this page for specifics. In general, specialty and brand-name drugs are more likely to require PA than generic equivalents.

Is there a copay card or patient assistance program for Choletec?

We haven't verified an active copay card or PAP for Choletec in our current data. Check NeedyMeds or RxAssist for independent directories, or submit what you find via our "Report a broken link" form.

What is Choletec used to treat?

Choletec (generic: Mebrofenin) is indicated for Acute Gallbladder Inflammation, Inflammation. Click any condition name on this page for more detail.

Does Choletec have a generic version?

The generic name for Choletec is Mebrofenin. Whether a generic is currently available depends on patent status — check the FDA Orange Book or ask your pharmacist. Generics are often substantially cheaper than brand-name drugs.

Choletec

Generic: Mebrofenin

Verified·Apr 23, 2026

Manufacturer: Bracco
NDC: 0270-0083
Route: INTRAVENOUS
ICD-10 indication: K81.0

Affordability Check

How much will you actually pay for Choletec?

In 30 seconds, see every legitimate way to afford Choletec — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Choletec

What is this medication? Choletec is a prescription radiopharmaceutical agent containing the active ingredient technetium Tc 99m mebrofenin. It is primarily used as a diagnostic tool in medical imaging procedures known as hepatobiliary scans, or HIDA scans. After being injected into the bloodstream, the medication is quickly absorbed by the liver and then secreted into the bile, allowing healthcare providers to visualize the function of the liver, gallbladder, and the surrounding bile duct system using a gamma camera.

This medication is specifically indicated for the diagnosis of several gallbladder and liver conditions, such as acute cholecystitis, which is the sudden inflammation of the gallbladder. It can also help detect blockages in the bile ducts, identify bile leaks after surgery, or assess the overall flow of bile from the liver into the small intestine. Because it contains a small amount of radioactive material, it is only administered by trained professionals in clinical or hospital settings for diagnostic purposes rather than for treating a specific disease.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

Cost Plus Drug Company

Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Mebrofenin.

Browse Cost Plus medications →

GoodRx

Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.

Lookup Choletec →

NeedyMeds

Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.

Search for Mebrofenin →

RxAssist

PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.

Search PAPs →

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Choletec. Official source: DailyMed (NLM) · Label effective Nov 29, 2025

Indications and usage

INDICATIONS AND USAGE Technetium Tc 99m Mebrofenin is indicated as a hepatobiliary imaging agent.

Dosage and administration

DOSAGE AND ADMINISTRATION The suggested intravenous dose range of Technetium Tc 99m Mebrofenin in the average patient (70 kg) is: Nonjaundiced patient: 74-185 MBq (2-5 mCi) Patient with serum bilirubin level greater than 1.5 mg/dL: 111-370 MBq (3-10 mCi) The patient dose should be measured by a suitable radioactivity calibration system immediately prior to administration. The patient should be in a fasting state, 4 hours is preferable. False positives (non-visualization) may result if the gallbladder has been emptied by ingestion of food. An interval of at least 24 hours should be allowed before repeat examination. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

Contraindications

CONTRAINDICATIONS Hypersensitivity to this compound.

Warnings

WARNINGS The theoretical possibility of allergic reactions should be considered in patients who receive multiple doses.

Adverse reactions

ADVERSE REACTIONS Urticaria and rash have been rarely reported with the use of Technetium Tc 99m Mebrofenin since market introduction. Rare cases of chills and nausea have been reported with related compounds. Infrequently, death has been reported in association with the use of this class of agents.

Use in pregnancy

Pregnancy Animal reproduction studies have not been conducted with Technetium Tc 99m Mebrofenin. It is also not known whether Technetium Tc 99m Mebrofenin can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Technetium Tc 99m Mebrofenin should be given to a pregnant woman only if the expected benefits to be gained clearly outweigh the potential hazards.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

Payer	PA	Step therapy	Copay tier
— Medicare Part D	—	—	—

Payer

Step therapy

Copay tier

—

Medicare Part D

—

Related drugs

How this page is sourced

Drug identity verified against openFDA NDC Directory.
Label text (when shown) originates from NLM DailyMed.
Copay and assistance URLs verified periodically; if you hit a broken link, tell us.